{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:39:59Z","timestamp":1782603599792,"version":"3.54.5"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Congenital nephrogenic diabetes insipidus (CNDI) is a rare hereditary tubular dysfunction caused mainly by X-linked recessive inheritance of<jats:italic>AVPR2<\/jats:italic>gene mutations. Pathogenic genes are a result of mutations in<jats:italic>AVPR2<\/jats:italic>on chromosome Xq28 and in<jats:italic>AQP2<\/jats:italic>on chromosome 12q13. The clinical manifestations of CNDI include polyuria, compensatory polydipsia, thirst, irritability, constipation, developmental delay, mental retardation, persistent decrease in the specific gravity of urine, dehydration, and electrolyte disorders (hypernatremia and hyperchloremia). Herein, we report a rare case of CNDI caused by an<jats:italic>AVPR2<\/jats:italic>mutation in a 2-year-old Chinese boy who had sustained polyuria, polydipsia, and irritability for more than 20 months. Laboratory examinations showed no obvious abnormality in blood sodium and chloride levels but decreased urine osmolality and specific gravity. Imaging findings were also normal. However, genetic analysis revealed a C &amp;gt; T transition leading to T273M missense mutations in AVPR2. We provided the boy a low-sodium diet and administered oral hydrochlorothiazide and indomethacin for 1 month, after which his clinical symptoms significantly improved. This case report suggests that CNDI is characterized by pathogenic T273M missense mutations alone and expands our understanding of the pathogenesis of CNDI.<\/jats:p>","DOI":"10.3389\/fped.2021.707452","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T07:50:15Z","timestamp":1626335415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case Report: A Case of Congenital Nephrogenic Diabetes Insipidus Caused by Thr273Met Mutation in Arginine Vasopressin Receptor 2"],"prefix":"10.3389","volume":"9","author":[{"given":"Li","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3390\/ijms18112385","article-title":"Hereditary nephrogenic diabetes insipidus: pathophysiology and possible treatment. An update","volume":"18","author":"Milano","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrendo.2011.100","article-title":"Familial forms of diabetes insipidus: clinical and 6 molecular characteristics","volume":"7","author":"Babey","year":"2011","journal-title":"Nat Rev Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1.2.1","DOI":"10.1002\/cpbi.27","article-title":"Searching online mendelian inheritance in man (OMIM): a knowledgebase of human genes and genetic phenotypes","volume":"58","author":"Amberger","year":"2017","journal-title":"Curr Protoc Bioinf."},{"key":"B4","doi-asserted-by":"publisher","first-page":"F1037","DOI":"10.1152\/ajprenal.00639.2012","article-title":"Inherited secondary nephrogenic diabetes insipidus: concentrating on humans","volume":"304","author":"Bockenhauer","year":"2013","journal-title":"Am J Physiol Renal Physiol."},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1515\/jpem-2019-0529","article-title":"From infancy to adulthood: challenges in congenital nephrogenic diabetes insipidus","volume-title":"J Pediatr Endocrinol Metab.","author":"Atmis","year":"2020"},{"key":"B6","doi-asserted-by":"publisher","first-page":"F1149","DOI":"10.1152\/ajprenal.00418.2016","article-title":"Physiological insights into novel therapies for nephrogenic diabetes insipidus","volume":"311","author":"Sands","year":"2016","journal-title":"Am J Physiol Renal Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5414\/CN109127","article-title":"Treatment regimens by pediatric nephrologists in children with congenital nephrogenic diabetes insipidus: a MWPNC study","volume":"89","author":"D'Alessandri-Silva","year":"2018","journal-title":"Clin Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000336333","article-title":"Diabetes insipidus\u2013diagnosis and management","volume":"77","author":"Di Iorgi","year":"2012","journal-title":"Horm Res Paediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/ng1092-99","article-title":"Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus","volume":"2","author":"van den Ouweland","year":"1992","journal-title":"Nat Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00431-018-3132-z","article-title":"Novel and recurrent variants in AVPR2 in 19 families with X-linked congenital nephrogenic diabetes insipidus","volume":"177","author":"Joshi","year":"2018","journal-title":"Eur J Ped."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1681\/ASN.2005040371","article-title":"Molecular biology of hereditary diabetes insipidus","volume":"16","author":"Mary","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10157-018-1544-8","article-title":"Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus","volume":"22","author":"Ando","year":"2018","journal-title":"Clin Exp Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1681\/ASN.V1161044","article-title":"Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus","volume":"11","author":"Arthus","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1877-1173(09)89002-9","article-title":"V2R mutations and nephrogenic diabetes insipidus","volume":"89","author":"Bichet","year":"2009","journal-title":"Prog Mol Biol Transl Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-3-030-25905-1_15","article-title":"Nephrogenic Insipidus Diabete","volume":"111","author":"Balla","year":"2019","journal-title":"Exp Suppl."},{"key":"B16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1039\/C0IB00018C","article-title":"Fluid-shearstress-induced translocation of aquaporin-2 and reorganization of actin cytoskeleton in renal tubular epithelial cells","volume":"3","author":"Jang","year":"2011","journal-title":"Integr Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pharmthera.2004.08.008","article-title":"Mutant G protein-coupled receptors as a cause of human diseases","volume":"104","author":"Schoneberg","year":"2004","journal-title":"Pharmacol Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"E2172","DOI":"10.3390\/cells9102172","article-title":"AQP2: mutations associated with congenital nephrogenic diabetes insipidus and regulation by post-translational modifications and protein-protein interactions","volume":"9","author":"Gao","year":"2020","journal-title":"Cells."},{"key":"B19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.beem.2016.02.010","article-title":"Genetic forms of nephrogenic diabetes insipidus (NDI): vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant)","volume":"30","author":"Bichet","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00467-012-2118-8","article-title":"Congenital nephrogenic diabetes insipidus:The current state of affairs","volume":"27","author":"Wesche","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"F257","DOI":"10.1152\/ajprenal.00491.2005","article-title":"Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus","volume":"291","author":"Robben","year":"2006","journal-title":"Am J Physiol Renal Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e88409","DOI":"10.1172\/jci.insight.88409","article-title":"Metformin improves urine concentration in rodents with nephrogenic diabetes insipidus","volume":"1","author":"Efe","year":"2016","journal-title":"JCI Insight."},{"key":"B23","doi-asserted-by":"publisher","first-page":"F882","DOI":"10.1152\/ajprenal.00411.2005","article-title":"Epac-mediated Ca(2+) mobilization and exocytosis in inner medullary collecting ductAm J Physiol Renal Physiol.","volume":"291","author":"Yip","year":"2006"},{"key":"B24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1042\/cs0660709","article-title":"Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus","volume":"66","author":"Monnens","year":"1984","journal-title":"Clin Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00467-009-1187-9","article-title":"Nephrogenic diabetes insipidus:treat with caution","volume":"24","author":"Boussemart","year":"2009","journal-title":"Pediatr NephroI."},{"key":"B26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fped.2020.00015","article-title":"A case of congenital nephrogenic diabetes insipidus caused by Thr108Met variant of aquaporin 2","volume":"8","author":"Ma","year":"2020","journal-title":"Front Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.18544\/PEDM-20.04.0018","article-title":"Response to low dose indomethacin in two children with nephrogenic diabetes insipidus","volume":"20","author":"Dayal","year":"2015","journal-title":"Pediatr Endocrinol Diabetes Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.beem.2016.02.006","article-title":"Diabetes insipidus in infants and children","volume":"30","author":"Dabrowski","year":"2016","journal-title":"Best Prac Res Clin Endocrinol Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12195","DOI":"10.1073\/pnas.0900130106","article-title":"Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists","volume":"106","author":"Robben","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/1087057116653925","article-title":"Identfication of potential pharmacoperones capable of rescuing the functionality of misfolded vasopressin 2 receptor involved in nephrogenic diabetes insipidus","volume":"21","author":"Smith","year":"2016","journal-title":"J Biomol Screen."},{"key":"B31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2826.2010.01983.x","article-title":"Potential of nonpeptide (ant)agonists to rescue vasopressinv2 receptor mutants for the treatment of x-linked nephrogenic diabetes insipidus","volume":"22","author":"Los","year":"2010","journal-title":"J. Neuroendocrinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-physiol-021113-170350","article-title":"Advances in understanding the urine-concentrating mechanism","volume":"76","author":"Sands","year":"2014","journal-title":"Annu Rev Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"13636","DOI":"10.1038\/ncomms13636","article-title":"Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway","volume":"7","author":"Ando","year":"2016","journal-title":"Nat Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1083\/jcb.200709177","article-title":"Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking","volume":"182","author":"Noda","year":"2008","journal-title":"J Cell Biol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.707452\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:48:58Z","timestamp":1672825738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.707452\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":34,"alternative-id":["10.3389\/fped.2021.707452"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.707452","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"article-number":"707452"}}